BIOLIT ApS: Financial statements 2019
CVR: 10068460
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,966,357 and a net result of DKK 1,475,787 compared with DKK 953,640 the year before. That is an increase of 56.6% compared with the year before. Equity amounted to DKK 7,081,909. The solvency ratio was 59.8%.
- Gross Profit
- 1,966,357 kr.
- Profit/Loss
- 1,475,787 kr.
- Equity
- 7,081,909 kr.
- Total Assets
- 11,851,649 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2 mio. | 1.5 mio. | 7.1 mio. | - |
| 2018 | - | 1.3 mio. | 954 t. | 5.6 mio. | - |
| 2017 | - | 1.4 mio. | 1.1 mio. | 4.7 mio. | - |
| 2016 | - | 1.8 mio. | 1.4 mio. | 3.6 mio. | - |
| 2015 | - | 1.1 mio. | 795 t. | 2.2 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.
